GHW International (GHW INTL) aksje
9933.HK
StengtGHW INTL
Market Cap
$1,558,128,000
Om GHW International (GHW INTL) aksje
GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People's Republic of China, Europe, Vietnam, the rest of Asia, and internationally. It operates through seven segments: Methylamine Industry Series; Goldenhighway New Materials; Advanced Materials Intermediates Series; Green Products; Healthcare and Wellness; Iodine Derivatives and Supporting Products; and Happy Elephant Selections. The Methylamine Industry Series segment consists of animal nutrition chemical products, such as choline chloride and betaine. Its Goldenhighway New Materials segment trades fine chemicals and polyurethane materials, as well as self-manufacturing polymer polyethers. The Advanced Materials Intermediates Series segment provides self-manufactured and traded fine chemical products and polyurethane materials products. Its Green Products segment produces cardanol products. The Healthcare and Wellness segment sells cefpodoxime proxetil dispersible tablets, as well as other pharmaceutical intermediates. Its Iodine Derivatives and Supporting Products segment sells iodine and iodine derivatives directly to customers, including organic and inorganic iodine derivatives. The Happy Elephant Planet segment sells nutrition products sourced from third parties. GHW International was founded in 1995 and is headquartered in Nanjing, the People's Republic of China.
Selskapsinformasjon
Nanjing, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.